Deferoxamine suppresses esophageal squamous cell carcinoma cell growth via ERK1/2 mediated mitochondrial dysfunction.
Lan, Linhua
Deferoxamine suppresses esophageal squamous cell carcinoma cell growth via ERK1/2 mediated mitochondrial dysfunction. [electronic resource] - Cancer letters 09 2018 - 132-143 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1872-7980
10.1016/j.canlet.2018.06.012 doi
Animals
Apoptosis
Carcinoma, Squamous Cell--drug therapy
Cell Movement
Cell Proliferation
Deferoxamine--pharmacology
Esophageal Neoplasms--drug therapy
Female
Gene Expression Regulation, Neoplastic--drug effects
Humans
Mice
Mice, Nude
Mitochondria--drug effects
Mitogen-Activated Protein Kinase 1--metabolism
Mitogen-Activated Protein Kinase 3--metabolism
Phosphorylation
Reactive Oxygen Species--metabolism
Siderophores--pharmacology
Signal Transduction
Tumor Cells, Cultured
Xenograft Model Antitumor Assays
Deferoxamine suppresses esophageal squamous cell carcinoma cell growth via ERK1/2 mediated mitochondrial dysfunction. [electronic resource] - Cancer letters 09 2018 - 132-143 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1872-7980
10.1016/j.canlet.2018.06.012 doi
Animals
Apoptosis
Carcinoma, Squamous Cell--drug therapy
Cell Movement
Cell Proliferation
Deferoxamine--pharmacology
Esophageal Neoplasms--drug therapy
Female
Gene Expression Regulation, Neoplastic--drug effects
Humans
Mice
Mice, Nude
Mitochondria--drug effects
Mitogen-Activated Protein Kinase 1--metabolism
Mitogen-Activated Protein Kinase 3--metabolism
Phosphorylation
Reactive Oxygen Species--metabolism
Siderophores--pharmacology
Signal Transduction
Tumor Cells, Cultured
Xenograft Model Antitumor Assays